CN106491856A - 透明质酸抑菌凝胶 - Google Patents
透明质酸抑菌凝胶 Download PDFInfo
- Publication number
- CN106491856A CN106491856A CN201610917525.0A CN201610917525A CN106491856A CN 106491856 A CN106491856 A CN 106491856A CN 201610917525 A CN201610917525 A CN 201610917525A CN 106491856 A CN106491856 A CN 106491856A
- Authority
- CN
- China
- Prior art keywords
- parts
- hyaluronic acid
- radix
- chinese medicine
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 49
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 49
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 49
- 230000003385 bacteriostatic effect Effects 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 40
- 239000000284 extract Substances 0.000 claims abstract description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 241000563984 Ampelopsis Species 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims abstract description 9
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims abstract description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 9
- 239000008213 purified water Substances 0.000 claims abstract description 9
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 7
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 5
- 238000000605 extraction Methods 0.000 claims abstract description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 14
- 238000001556 precipitation Methods 0.000 claims description 10
- PXXLQQDIFVPNMP-UHFFFAOYSA-N 3-(diethylcarbamoyl)benzoic acid Chemical compound CCN(CC)C(=O)C1=CC=CC(C(O)=O)=C1 PXXLQQDIFVPNMP-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 239000000287 crude extract Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- -1 mixing is Even Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 229960003910 promethazine Drugs 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 2
- 210000002429 large intestine Anatomy 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 13
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 206010072170 Skin wound Diseases 0.000 abstract description 2
- 230000000474 nursing effect Effects 0.000 abstract description 2
- 230000002980 postoperative effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 30
- 230000000694 effects Effects 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000000589 cicatrix Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000001408 fungistatic effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 230000001775 anti-pathogenic effect Effects 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种透明质酸抑菌凝胶,原料重量份组成为:透明质酸50‑60份、中药提取物30‑40份、DCBA15‑20份、乙醇3‑5份、丙三醇5‑8份、纯化水10‑15份;所述的中药提取物原料为白蔹、白芷、白茯苓、葛根、天花粉、白术、蒲公英、连翘、金银花、赤芍、丹皮、苦参、甘草。本发明透明质酸抑菌凝胶对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌具有抑菌作用,涂抹于皮肤,形成皮肤保护膜,适用于皮肤抑菌及术后皮肤伤口的抑菌保护和日常肌肤护理。
Description
技术领域
本发明属于医药技术领域,涉及一种抑菌凝胶,具体涉及一种透明质酸抑菌凝胶。
背景技术
透明质酸是一种多功能基质,是人体皮肤表皮及真皮的主要成分之一。透明质酸具有高黏度、可塑性、渗透性、独特的流变学特性以及良好的生物相容性,故在这样的组织中水分运输缓慢,从而起到调节水分分布的作用。这使得透明质酸对细胞间隙的蛋白质和代谢产物具有调节作用,同时也起到了润滑剂的显著作用。研究显示,透明质酸在调节胚胎发生过程中各种细胞成分的移行行为起着关键性作用。同时,它在组织修复过程尤其是皮肤的创伤愈合过程中发挥重要做作用。
人体表面覆盖的皮肤和粘膜是人体抵抗外部致病微生物侵袭的防线,创伤发生时易被感染,目前市场上常见的皮肤敷料杀菌效果不明显,或者有明显的刺激性,使用不舒适。因此,为了解决皮肤受细菌或真菌感染后出现的瘙痒、红肿、疼痛等问题,市场上对于有效、优质的抑菌凝胶需求巨大。
发明内容
本发明针对现有技术中存在的上述不足,提供一种透明质酸抑菌凝胶,不含铅、砷、汞等重金属及激素、抗生素等成分,具有天然、安全、无毒、无刺激的优势,适用于各类人群。
本发明技术方案如下:
一种透明质酸抑菌凝胶,原料重量份组成为:透明质酸50-60份、中药提取物30-40份、DCBA15-20份、乙醇3-5份、丙三醇5-8份、纯化水10-15份;所述的中药提取物,中药原料重量份组成为白蔹25-35份、白芷25-35份、白茯苓25-30份、葛根20-30份、天花粉20-25份、白术20-25份、蒲公英20-25份、连翘12-15份、金银花10-15份、赤芍10-15份、丹皮10-15份、苦参10-15份、甘草10-15份。
所述的透明质酸摩尔组成为:分子量1.8-2.2×106的透明质酸50-55%、分子量1.0-1.8×106的透明质酸25-30%、分子量0.4-1.0×106的透明质酸 20-30%。
所述的中药提取物,提取方法为:各中药原料研磨成粉末过100目筛,混合均匀,加3-5倍体积的95%乙醇回流提取3-4h,粗提液中加入24-30mg/ml盐酸异丙嗪-β环糊精形成包络物,减压蒸除溶剂,得到挥发油浸膏;回流后的药渣干燥,超微粉碎,用5-10倍体积的水浸泡40-48h,过滤,分离滤液、滤渣,滤液调pH值至1.0-3.0,收集沉淀,得沉淀提取物,滤渣用6倍体积的水蒸馏,收集初蒸馏液,再对初蒸馏液进行重蒸馏,收集重蒸馏液;合并挥发油浸膏、沉淀提取物、重蒸馏液,混合均匀,浓缩至含水量65-75wt%,得中药提取物。
所述的透明质酸抑菌凝胶制备方法为:将DCBA、中药提取物30-40份、乙醇、丙三醇、纯化水混合均匀,过滤,搅拌下加入透明质酸,即得。
所述的透明质酸抑菌凝胶对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌具有抑菌作用。
本发明透明质酸抑菌凝胶涂抹于皮肤,形成皮肤保护膜,适用于皮肤抑菌及术后皮肤伤口的抑菌保护和日常肌肤护理。
本发明透明质酸含有大,中,小不同分子量的透明质酸成分;大分子透明质酸在皮肤表面形成一层透气的薄膜,对于治疗部位进行敷贴。使皮肤光滑湿润的同时可杀灭细菌并阻隔外来灰尘与紫外线的侵入,保护皮肤免受侵害。中小分子透明质酸可携带药物迅速渗透皮肤,使水分进入细胞间歇,促进蛋白质结合,发挥正常的细胞代谢作用,加快细胞再生。同时携带的抑菌消炎成分保护细胞不受病原菌侵害,快速修复皮肤组织,提高创口愈合再生能力,减少疤痕。小分子透明质酸通过渗入真皮层,轻微扩张毛细血管,增加血液循环,改善皮肤营养代谢。同时携带的中药成分,又具有清热解毒,活血化瘀等功效从而起到美白淡斑的作用。
透明质酸和DCBA(2,4-二氯苄醇),加入中药提取物并配合其他辅料,成功配制出一种透明质酸抑菌凝胶。DCBA为一种抑菌成分,是通过使病原微生物蛋白质变性、沉淀或凝固而起到杀菌作用的;中药提取物为纯天然药物成分,对于避免因治疗后皮肤色素形成有着良好的改善效果,其中药成分与凝胶完美融合后外敷,使药物直接作用于皮肤,加入的HA成分可使中药快速渗透进入肌肤,直达基底,使中草药的生物利用度更充分,药效作用更持久。具有清热解毒,活血化瘀,祛腐生肌,改善局部皮肤血液循环,抑制黑色素形成,淡化皮肤色斑、润白养颜、祛皱等功效。
本发明透明质酸抑菌凝胶有益效果:
1)对于痤疮或易于形成皮肤凹坑等的皮肤损伤,在治疗的同时,可使患处皮肤充分吸收水分,避免皮肤因治疗引起的皮肤凹坑的产生。如直接用于痤疮皮肤表面,其抑菌成分可直接作用于毛囊,有效对抗毛囊内形成痤疮的有害菌,起到消炎、杀菌作用,并同时透明质酸渗透到细胞间隙,与蛋白质结合形成蛋白凝胶,将细胞粘在一起,发挥正常的细胞代谢作用,锁住水分填平凹痕。并清热解毒,活血化瘀淡化斑痕;
2)有效消除活性氧自由基(ROS),增强细胞抗氧化能力,提升肌肤对紫外线、灰尘、雾霾等外界因素对皮肤的损伤的防御力;
3)对于微创伤、创口及及物理治疗后的创面修复和保护有很好的效果。可起到快速愈合,淡化瘢痕的作用;
4)可以用于激光,光子美容仪,微针等微整形手术一起配套使用,保护微创手术创面,促进创面修复,杀菌消炎,缓解皮肤干燥,祛斑、美白。
具体实施方案
下面结合具体实施例进一步描述本发明,在不脱离本发明上述技术思想情况下,根据本领域普通技术知识和惯用手段做出的各种替换或变更,均包括在本发明的范围内。
实施例1
制备中药提取物
1)中药原料重量份组成为白蔹30份、白芷30份、白茯苓28份、葛根25份、天花粉23份、白术22份、蒲公英22份、连翘13份、金银花12份、赤芍12份、丹皮12份、苦参12份、甘草12份。
2)上述各中药原料研磨成粉末过100目筛,混合均匀,加3倍体积的95%乙醇回流提取4h,粗提液中加入25mg/ml盐酸异丙嗪-β环糊精形成包络物,减压蒸除溶剂,得到挥发油浸膏;回流后的药渣干燥,超微粉碎,用8倍体积的水浸泡45h,过滤,分离滤液、滤渣,滤液调pH值至2.5,收集沉淀,得沉淀提取物,滤渣用6倍体积的水蒸馏,收集初蒸馏液,再对初蒸馏液进行重蒸馏,收集重蒸馏液;合并挥发油浸膏、沉淀提取物、重蒸馏液,混合均匀,浓缩至含水量68wt%,得中药提取物。
实施例2
一种透明质酸抑菌凝胶,原料重量份组成为:透明质酸55份、中药提取物35份、DCBA 18份、乙醇4份、丙三醇5-86份、纯化水12份;
其中,中药提取物,中药原料重量份组成为白蔹30份、白芷30份、白茯苓28份、葛根25份、天花粉23份、白术22份、蒲公英22份、连翘13份、金银花12份、赤芍12份、丹皮12份、苦参12份、甘草12份,制备方法同实施例1。
透明质酸摩尔组成为:分子量1.8-2.2×106的透明质酸53%、分子量1.0-1.8×106的透明质酸27%、分子量0.4-1.0×106的透明质酸 30%。
将DCBA、中药提取物30-40份、乙醇、丙三醇、纯化水混合均匀,过滤,搅拌下加入透明质酸,即得。
实施例3
一种透明质酸抑菌凝胶,原料重量份组成为:透明质酸50份、中药提取物30份、DCBA 15份、乙醇3份、丙三醇5份、纯化水10份;
其中,中药提取物,中药原料重量份组成为白蔹25份、白芷25份、白茯苓25份、葛根20份、天花粉20份、白术20份、蒲公英20份、连翘12份、金银花10份、赤芍10份、丹皮10份、苦参10份、甘草10份,制备方法同实施例1。
透明质酸摩尔组成为:分子量1.8-2.2×106的透明质酸55%、分子量1.0-1.8×106的透明质酸25%、分子量0.4-1.0×106的透明质酸 20%。
实施例4
一种透明质酸抑菌凝胶,原料重量份组成为:透明质酸60份、中药提取物40份、DCBA 20份、乙醇5份、丙三醇8份、纯化水15份;
其中,中药提取物,中药原料重量份组成为白蔹35份、白芷35份、白茯苓30份、葛根30份、天花粉25份、白术25份、蒲公英25份、连翘15份、金银花15份、赤芍15份、丹皮15份、苦参15份、甘草15份,制备方法同实施例1。
透明质酸摩尔组成为:分子量1.8-2.2×106的透明质酸50%、分子量1.0-1.8×106的透明质酸30%、分子量0.4-1.0×106的透明质酸 20%。
对比例1
同实施例2,不同之处在于中药提取物制备方法为普通醇提。
对比例2
同实施例2,不同之处在于中药提取物原料组成为白蔹30份、白茯苓28份、白术22份、蒲公英22份、连翘13份、金银花12份、赤芍12份、苦参12份、甘草12份。
对比例3
同实施例2,不同之处在于中药提取物原料组成为白蔹30份、白芷30份、白茯苓28份、天花粉23份、蒲公英22份、金银花12份、赤芍12份、苦参12份、甘草12份。
对比例4
一种抑菌剂,同实施例2,不同之处在于不加透明质酸。
实施例及对比例抑菌效果检测,
对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌抑菌效果,见表1:
表1
将本发明实施例2透明质酸抑菌凝胶抑菌用于痤疮皮肤表面,3-5天症状减轻,15-20天即可痊愈,且皮肤无凹坑、疤痕产生。
本发明透明质酸抑菌凝胶抑菌效果稳定性试验
依据《消毒技术规范》2002年版,将由实施例2制得的抑菌凝胶于 54±1℃恒温箱中放置14天,然后在试验温度20±2℃下分别检测该抑菌凝胶存放前后对金黄色葡萄球菌的抑菌效果,如下表2所示:
表2
。
Claims (5)
1.一种透明质酸抑菌凝胶,其特征在于:原料重量份组成为:透明质酸50-60份、中药提取物30-40份、DCBA15-20份、乙醇3-5份、丙三醇5-8份、纯化水10-15份;所述的中药提取物,中药原料重量份组成为白蔹25-35份、白芷25-35份、白茯苓25-30份、葛根20-30份、天花粉20-25份、白术20-25份、蒲公英20-25份、连翘12-15份、金银花10-15份、赤芍10-15份、丹皮10-15份、苦参10-15份、甘草10-15份。
2.根据权利要求1所述的透明质酸抑菌凝胶,其特征在于:所述的透明质酸摩尔组成为:分子量1.8-2.2×106的透明质酸50-55%、分子量1.0-1.8×106的透明质酸25-30%、分子量0.4-1.0×106的透明质酸 20-30%。
3.根据权利要求1所述的透明质酸抑菌凝胶,其特征在于:所述的中药提取物,提取方法为:各中药原料研磨成粉末过100目筛,混合均匀,加3-5倍体积的95%乙醇回流提取3-4h,粗提液中加入24-30mg/ml盐酸异丙嗪-β环糊精形成包络物,减压蒸除溶剂,得到挥发油浸膏;回流后的药渣干燥,超微粉碎,用5-10倍体积的水浸泡40-48h,过滤,分离滤液、滤渣,滤液调pH值至1.0-3.0,收集沉淀,得沉淀提取物,滤渣用6倍体积的水蒸馏,收集初蒸馏液,再对初蒸馏液进行重蒸馏,收集重蒸馏液;合并挥发油浸膏、沉淀提取物、重蒸馏液,混合均匀,浓缩至含水量65-75wt%,得中药提取物。
4.根据权利要求1所述的透明质酸抑菌凝胶,其特征在于:制备方法为:将DCBA、中药提取物30-40份、乙醇、丙三醇、纯化水混合均匀,过滤,搅拌下加入透明质酸,即得。
5.根据权利要求1所述的透明质酸抑菌凝胶,其特征在于:对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌具有抑菌作用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610917525.0A CN106491856A (zh) | 2016-10-21 | 2016-10-21 | 透明质酸抑菌凝胶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610917525.0A CN106491856A (zh) | 2016-10-21 | 2016-10-21 | 透明质酸抑菌凝胶 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106491856A true CN106491856A (zh) | 2017-03-15 |
Family
ID=58318268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610917525.0A Pending CN106491856A (zh) | 2016-10-21 | 2016-10-21 | 透明质酸抑菌凝胶 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106491856A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108904542A (zh) * | 2018-09-06 | 2018-11-30 | 海安百优基质生物工程有限公司 | 用于抑菌修复的手性超分子水凝胶皮肤软膏的制备方法 |
CN109528832A (zh) * | 2019-01-22 | 2019-03-29 | 宜春学院 | 一种伤口清洗液及其制备方法 |
CN111096934A (zh) * | 2019-08-16 | 2020-05-05 | 华熙生物科技股份有限公司 | 一种抑制痤疮的凝胶 |
CN112450230A (zh) * | 2020-11-03 | 2021-03-09 | 南京植创生物技术研究院有限公司 | 复配植物消毒剂及其制备方法 |
CN113081928A (zh) * | 2021-04-29 | 2021-07-09 | 云南赛森生物科技有限公司 | 一种植物抑菌凝胶及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103720865A (zh) * | 2013-12-20 | 2014-04-16 | 张翠月 | 一种治疗痤疮的中药面膜及其制备方法 |
CN103860526A (zh) * | 2013-11-26 | 2014-06-18 | 华熙福瑞达生物医药有限公司 | 一种含透明质酸的消毒剂、其制备方法及用途 |
CN105833134A (zh) * | 2016-05-19 | 2016-08-10 | 季资朝 | 一种治疗皮炎湿疹的中药组合物凝胶及其制备方法 |
-
2016
- 2016-10-21 CN CN201610917525.0A patent/CN106491856A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103860526A (zh) * | 2013-11-26 | 2014-06-18 | 华熙福瑞达生物医药有限公司 | 一种含透明质酸的消毒剂、其制备方法及用途 |
CN103720865A (zh) * | 2013-12-20 | 2014-04-16 | 张翠月 | 一种治疗痤疮的中药面膜及其制备方法 |
CN105833134A (zh) * | 2016-05-19 | 2016-08-10 | 季资朝 | 一种治疗皮炎湿疹的中药组合物凝胶及其制备方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108904542A (zh) * | 2018-09-06 | 2018-11-30 | 海安百优基质生物工程有限公司 | 用于抑菌修复的手性超分子水凝胶皮肤软膏的制备方法 |
CN109528832A (zh) * | 2019-01-22 | 2019-03-29 | 宜春学院 | 一种伤口清洗液及其制备方法 |
CN111096934A (zh) * | 2019-08-16 | 2020-05-05 | 华熙生物科技股份有限公司 | 一种抑制痤疮的凝胶 |
CN111096934B (zh) * | 2019-08-16 | 2022-02-08 | 华熙生物科技股份有限公司 | 一种抑制痤疮的凝胶 |
CN112450230A (zh) * | 2020-11-03 | 2021-03-09 | 南京植创生物技术研究院有限公司 | 复配植物消毒剂及其制备方法 |
CN113081928A (zh) * | 2021-04-29 | 2021-07-09 | 云南赛森生物科技有限公司 | 一种植物抑菌凝胶及其制备方法和应用 |
CN113081928B (zh) * | 2021-04-29 | 2023-06-06 | 云南赛森生物科技有限公司 | 一种植物抑菌凝胶及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106334067B (zh) | 含银离子抗菌剂的妇科凝胶、制备方法及应用 | |
JP6530817B2 (ja) | ニキビ除去スキンケア製品とその製造方法 | |
CN106491856A (zh) | 透明质酸抑菌凝胶 | |
CN103735458B (zh) | 一种皮肤抗敏修护组合物 | |
KR101547920B1 (ko) | 두피와 모발의 보호를 위한 천연 샴푸바 및 그 제조방법 | |
CN106109534A (zh) | 含银离子抗菌剂的止痒修复液、制备方法及应用 | |
CN101062289A (zh) | 治疗痛风的外用药物组合物 | |
CN111557877B (zh) | 一种含有积雪草提取物的牙膏及其制备方法 | |
CN109646712A (zh) | 一种胶态硫液体敷料及其制备方法 | |
CN108785200B (zh) | 一种抗菌、祛痘、抗皱的银离子保湿面膜液、面膜及其制备方法 | |
CN104096114B (zh) | 清咽润喉糖 | |
CN103520406B (zh) | 一种治疗湿疹的中药涂剂及其制备方法 | |
RU2328301C2 (ru) | Мазь антибактериальная, противовоспалительная | |
CN107496792A (zh) | 一种消炎抗菌治疗灰指甲的凝胶剂及其制备方法 | |
CN115518127B (zh) | 一种抑菌抗炎消肿止痒乳膏及其制备方法 | |
CN108158912B (zh) | 一种水飞蓟祛痘修痕凝胶及其制备方法 | |
CN110812377B (zh) | 一种痤疮治疗修复组合物及其应用 | |
CN113713018A (zh) | 一种湿疹膏的中药组合物及其制作工艺 | |
CN1283391A (zh) | 一种灭菌萃取液 | |
CN113616801A (zh) | 含有黄芩提取物的具有防腐、抑菌制剂的制备方法及其应用 | |
CN111544328A (zh) | 一种足部喷剂及其制备方法 | |
KR101920908B1 (ko) | 녹차를 함유하는 구강청정제 | |
CN108815235A (zh) | 一种外用植物源止痒消炎膏及其制备方法 | |
CN1251750C (zh) | 皮肤护理保健液 | |
KR101663995B1 (ko) | 천연물로부터 유래된 아토피 피부염 완화용 피부 외용제의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170315 |
|
RJ01 | Rejection of invention patent application after publication |